CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability.

[1]  D. Channe Gowda,et al.  Facile Transfer Hydrogenation of Azo Compounds to Hydrazo Compounds and Anilines by Using Raney Nickel and Hydrazinium Monoformate , 2004 .

[2]  David A. Lustig,et al.  New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties. , 2004, Bioorganic & medicinal chemistry letters.

[3]  S. Kerwar,et al.  Novel inhibitors of fatty acid oxidation as potential metabolic modulators. , 2004, Bioorganic & medicinal chemistry letters.

[4]  J. Zablocki,et al.  Microwave‐Assisted One‐Step Synthesis of Substituted 2‐Chloromethyl‐1,3,4‐oxadiazoles , 2004 .

[5]  Zhihe Li,et al.  Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF). , 2004, Bioorganic & medicinal chemistry letters.

[6]  L. Belardinelli,et al.  Conditional-dependent effects of CVT-4325, a novel fatty acid oxidation inhibitor, on palmitate utilization , 2003 .

[7]  J. Hill,et al.  Role of Metabolically Active Drugs in the Management of Ischemic Heart Disease , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[8]  R. Miller,et al.  Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonist. , 2000, Bioorganic & medicinal chemistry letters.

[9]  C. Strader,et al.  Synthesis and SAR of benzyl and phenoxymethylene oxadiazole benzenesulfonamides as selective beta3 adrenergic receptor agonist antiobesity agents. , 2000, Bioorganic & medicinal chemistry letters.

[10]  L. Terenius,et al.  Design, synthesis, and evaluation of Phe-Gly mimetics: heterocyclic building blocks for pseudopeptides. , 1999, Journal of medicinal chemistry.

[11]  J. Mccormack,et al.  Ranolazine: a novel metabolic modulator for the treatment of angina. , 1998, General pharmacology.

[12]  J. Mccormack,et al.  Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. , 1996, Circulation.

[13]  U. Hacksell,et al.  Synthesis of 1,2,4-Oxadiazole-, 1,3,4-Oxadiazole-, and 1,2,4-Triazole-Derived Dipeptidomimetics , 1995 .

[14]  W. Herron,et al.  The characterization of the metabolites of ranolazine in man by liquid chromatography mass spectrometry. , 1995, Rapid communications in mass spectrometry : RCM.

[15]  B. Cannon,et al.  Overview--preparation and properties of mitochondria from different sources. , 1979, Methods in enzymology.